Skip to content
Disclosery

Qube Research & Technologies Ltd: ACCO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Qube Research & Technologies Ltd on ACCO, newest first. How the timeline and the estimate are built.

Qube Research & Technologies Ltd held 104,165 ACCO shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 104,165 shares
    Change vs previous 13F -183,856 shares

    <0.01% of the 13F portfolio, value $433,326.

    13F-HR 0001729829-26-000014 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 288,021 shares
    Change vs previous 13F +238,867 shares

    <0.01% of the 13F portfolio, value $864,063.

    13F-HR 0001729829-26-000004 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 49,154 shares
    Change vs previous 13F -293,894 shares

    <0.01% of the 13F portfolio, value $183,344.

    13F-HR 0001729829-26-000002 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 343,048 shares
    Change vs previous 13F -212,088 shares

    <0.01% of the 13F portfolio, value $1,368,762.

    13F-HR 0001729829-25-000053 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 555,136 shares
    Change vs previous 13F +232,354 shares

    <0.01% of the 13F portfolio, value $1,987,387.

    13F-HR 0001729829-25-000050 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 322,782 shares
    Change vs previous 13F -194,704 shares

    <0.01% of the 13F portfolio, value $1,352,457.

    13F-HR 0001729829-25-000048 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 517,486 shares
    Change vs previous 13F +220,287 shares

    <0.01% of the 13F portfolio, value $2,716,802.

    13F-HR 0001729829-25-000045 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 297,199 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,625,679.

    13F-HR 0001729829-24-000013 filed by Qube Research & Technologies Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).